• Source: Alphacetylmethadol

Alphacetylmethadol (INN), or α-acetylmethadol (AAM), is a synthetic opioid analgesic. Its levorotary enantiomer, levacetylmethadol, is an FDA-approved treatment for opioid addiction; however as of 2003 it is no longer used in the United States for this purpose. Alphacetylmethadol is very similar in structure to methadone, a widely prescribed treatment for opioid addiction. In the United States, it is a Schedule I controlled substance under the Controlled Substances Act (presumably because it was never marketed in the US, as is the case with other common opiate/opioid medications such as heroin and prodine), with an ACSCN of 9603 and a 2013 annual manufacturing quota of 2 grammes.




See also


Levacetylmethadol
Acetylmethadol
Betacetylmethadol
Alphamethadol




References

Kata Kunci Pencarian:

• Alphacetylmethadol
• Betacetylmethadol
• Brazilian Controlled Drugs and Substances Act
• Levacetylmethadol
• Acetylmethadol
• List of Schedule I controlled substances (U.S.)
• Alphamethadol
• Misuse of Drugs Act 1971
• Drug policy of India
• List of drugs: Al